Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-22-077837

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Androski Lindsay · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-07-01 Grant or award : show line 1 in the form Stock Options (Right to Buy) +40,000 40,000 D
Loading xslF345X03/tm2220578-1_4seq1.xml…